Citation: James C. L. Chow. Recent progress in Monte Carlo simulation on gold nanoparticle radiosensitization[J]. AIMS Biophysics, 2018, 5(4): 231-244. doi: 10.3934/biophy.2018.4.231
[1] | Baolin Kang, Xiang Hou, Bing Liu . Threshold control strategy for a Filippov model with group defense of pests and a constant-rate release of natural enemies. Mathematical Biosciences and Engineering, 2023, 20(7): 12076-12092. doi: 10.3934/mbe.2023537 |
[2] | Guodong Li, Wenjie Li, Ying Zhang, Yajuan Guan . Sliding dynamics and bifurcations of a human influenza system under logistic source and broken line control strategy. Mathematical Biosciences and Engineering, 2023, 20(4): 6800-6837. doi: 10.3934/mbe.2023293 |
[3] | Hao Zhou, Xia Wang, Sanyi Tang . Global dynamics of non-smooth Filippov pest-natural enemy system with constant releasing rate. Mathematical Biosciences and Engineering, 2019, 16(6): 7327-7361. doi: 10.3934/mbe.2019366 |
[4] | Yi Yang, Lirong Liu, Changcheng Xiang, Wenjie Qin . Switching dynamics analysis of forest-pest model describing effects of external periodic disturbance. Mathematical Biosciences and Engineering, 2020, 17(4): 4328-4347. doi: 10.3934/mbe.2020239 |
[5] | Cunjuan Dong, Changcheng Xiang, Wenjin Qin, Yi Yang . Global dynamics for a Filippov system with media effects. Mathematical Biosciences and Engineering, 2022, 19(3): 2835-2852. doi: 10.3934/mbe.2022130 |
[6] | A. K. Misra, Jyoti Maurya, Mohammad Sajid . Modeling the effect of time delay in the increment of number of hospital beds to control an infectious disease. Mathematical Biosciences and Engineering, 2022, 19(11): 11628-11656. doi: 10.3934/mbe.2022541 |
[7] | Dan Shi, Shuo Ma, Qimin Zhang . Sliding mode dynamics and optimal control for HIV model. Mathematical Biosciences and Engineering, 2023, 20(4): 7273-7297. doi: 10.3934/mbe.2023315 |
[8] | Fang Wang, Juping Zhang, Maoxing Liu . Dynamical analysis of a network-based SIR model with saturated incidence rate and nonlinear recovery rate: an edge-compartmental approach. Mathematical Biosciences and Engineering, 2024, 21(4): 5430-5445. doi: 10.3934/mbe.2024239 |
[9] | David Moreno-Martos, Sean Foley, Benjamin Parcell, Dumitru Trucu, Raluca Eftimie . A computational investigation of COVID-19 transmission inside hospital wards and associated costs. Mathematical Biosciences and Engineering, 2022, 19(7): 6504-6522. doi: 10.3934/mbe.2022306 |
[10] | Yun Liu, Yuhong Huo . Predefined-time sliding mode control of chaotic systems based on disturbance observer. Mathematical Biosciences and Engineering, 2024, 21(4): 5032-5046. doi: 10.3934/mbe.2024222 |
Emerging and reemerging infectious disease, for instance, the 2003 severe acute respiratory syndrome (SARS) [27,19], the 2009 H1N1 influenza epidemic [22,38,44], Ebola virus disease in west Africa [42,23] and Zika virus [2] have become major causes of mortality and morbidity in emergencies, where collapsing health service and disease control programmes, poor access to health care, interrupted supplies and logistics are often the cruel reality. Global public health systems of surveillance and response are used to fighting to curb infectious diseases by controlling it at source [30] or slowing down its development course [20,5]. An efficient way to containing a disease during an outbreak is to provide as much as possible medical resources, including sufficient medicine, health care workers, hospital beds and etc. To explore the impact of limited medical resources on the control of infectious diseases and evaluate the possible control strategies, most of the available compartmental models either assume a constant treatment rate or adopt medical resources dependent continuous functions to represent the treatment rates [41,45]. However, change of the level of available medical resources were not well modeled in these models since usually the allocation and change of medical resources do not occur in a continuous way.
As WHO statistic information system referred, in-patient beds density, as one of the available indicators, can be adopted to access the level of health service delivery [43]. Hence, the number of available hospital beds per 10000 population, termed as hospital bed-population ratio (HBPR), is always used by the public health as an approach of capturing availability of health services delivery. The variations of the level of infected cases between communities and hospitals usually make it difficult for the public health to evaluate and decide the number of hospital beds needed to control the epidemic [1]. Setting sufficient beds to cover peak demands usually leads to quite a lot of beds idle at other times while reducing hospital beds to improving average bed occupancy level results in frequent overflows and congestions within hospital. Hence, quantifying the impact of the number of hospital beds for epidemics control remains a challenge and is therefore an important issue for public health.
Recently, there have been modeling studies dedicated to exploring the impact of the number of hospital beds on the future containing of disease [35,24,33,43,34]. Some have modeled the impact by embedding a continuous function in terms of the number of hospital beds into the recovery rate [35,34]. In fact, the medical resources used to contain the disease are always limited and the policy to intervene the disease varies depending on the number of infected individuals [32]. In particular, treatment rate depends not only on the available resources of health system to the public but also on the total infected individuals seeking treatment. On one hand, the capacity of the hospital settings, especially the number of health workforce and the facilities of the hospital are vital factors for efficient treatment of infection. On the other hand, the proportion of infected individuals getting access of the medical establishment to cure may change. Therefore, a considerable issue is to model and study the impact of these factors on the control of epidemic disease.
In this paper, we choose the number of infected cases as an index to propose a threshold policy [37,44,31,28] (of course, we could adopt the size of population who are exposed to the virus or the total number of susceptible and infected individuals). In this case, the control strategy is formulated by using a piecewise smooth function which depends on the density of infected individuals. The purpose of this paper is then to formulate a novel mathematical model subject to the threshold policy to study a Filippov system [21,39,8,4]. In particular, when the number of infected individuals is below the threshold level, the per capita treatment rate will be a constant, representing the maximum per capita treatment rate; while above the level, a weaker treatment policy will be adopted by incorporating the impact of the capacity and limited resources of the health care system in terms of the HBPR and depends on the number of the infected individuals. Filippov systems have been widely investigated [7,11,3,6], especially the sliding mode bifurcations in generic Filippov systems [17,26,18,29] and the numerical methods for them [15,13]. This type of systems have gained considerable attention in recent years since they not only behave differently from smooth systems but also found very important applications in many fields, such as pest control [37], power control in circuit [9], control of ecological systems [14], evolutionary biology [12,10], forest fire [16] and mechanical systems with friction [25], and a few work found in the disease controlling[32,40]. In [32], two parameters are adopted to model the treatment proportion for selective treatment measure due to the limited medical resources while we will model the hospital bed-population ratio by a parameter in this work.
The main purpose of this paper is to explore the impact of hospital bed-population ratio (i.e. HBPR) on disease control using a Filippov system. Some natural questions to ask include how does the level of infected cases combined with the HBPR affect the existence of the sliding modes, pseudo-equilibrium and sliding bifurcation? Further, how does the threshold policy affect the course of disease transmission and control outcome? To address these questions, we will focus on the sliding mode dynamics as well as the rich sliding bifurcations with variation of the threshold level. The rest of this paper is organized as follows. In Section 2, a piecewise defined treatment programme, which is termed as switching policy in control literature, is proposed to incorporate the level of infected cases and the impact of HBPR into the epidemic model. The sliding mode as well as all possible critical points are examined in Section 3. In Section 4, we study the sliding bifurcation including local sliding bifurcation and global sliding bifurcation. In Section 5, we investigate the impact of some key parameters on the evolution of the epidemic disease. Some concluding remarks and biological interpretations will be presented in the last section.
As mentioned in the introduction, the medical resources can not always meet the increasing treatment demand of the infecteds. As WHO referred, we adopt the hospital bed-population ratio (i.e. HBPR and denoted by
We divide the population into two classes: susceptible (
$
\left\{
dSdt=Λ−μS−βSIS+I+H(I,ϵ)I,dIdt=βSIS+I−μI−νI−H(I,ϵ)I
\right.
$
|
(1) |
with
$ H(I, \epsilon) = \epsilon H_1(b, I)+(1-\epsilon)h_1 $ | (2) |
and
$
\epsilon = \left\{
0,σ(S,I,Ic)<0,1,σ(S,I,Ic)>0,
\right.
$
|
(3) |
where
In particular, the function
$
H(I, \epsilon) = \left\{ h1,I<Ic,h0+(h1−h0)bb+I,I>Ic. \right.
$
|
Model system (1) with (2) and (3) is a piecewise smooth dynamical system (PWS)[3]. In particular, it subjects to a threshold value and is indeed a so-called Filippov system [21], i.e. systems of ordinary differential equations (ODES) with non-smooth right-hand sides.
Denote
$X1(S,I)=(Λ−μS−βSIS+I+h1I,βSIS+I−μI−νI−h1I)T˙=(f11(S,I),f12(S,I))T,X2(S,I)=(Λ−μS−βSIS+I+[h0+(h1−h0)bb+I]I,βSIS+I−μI−νI−[h0+(h1−h0)bb+I]I)T˙=(f21(S,I),f22(S,I))T,
$
|
then system (1) with (2) and (3) can be written as the following Filippov system
$
\frac{\mathrm{d}Z}{\mathrm{d}t} = \left\{
X1(S,I),σ(I,Ic)<0X2(S,I),σ(I,Ic)>0.
\right.
$
|
(4) |
The attraction region of system (4) is
$\Sigma = \{(S, I):I = I_c, (S, I)\in R^2_+\}, $ |
which splits
$G1(S,I)={(S,I):I<Ic,(S,I)∈R2+},G2(S,I)={(S,I):I>Ic,(S,I)∈R2+}.
$
|
For convenience, system (4) restricted in region
Definition 2.1. Regular equilibrium of system (4) refers to those equilibria located in the region
A real equilibrium
$X_1(Z_*) = 0, \ \sigma(Z_*)<0$ |
or
$X_2(Z_*) = 0, \ \sigma(Z_*)>0.$ |
A virtual equilibrium
$X_1(Z_*) = 0, \ \sigma(Z_*)>0$ |
or
$X_2(Z_*) = 0, \ \sigma(Z_*)<0.$ |
Definition 2.2. A boundary equilibrium
$X_1(Z_*) = 0, \ \sigma(Z_*) = 0$ |
or
$X_2(Z_*) = 0, \ \sigma(Z_*) = 0.$ |
Definition 2.3. A tangency point
$X_i\sigma(Z) = \langle\sigma(Z), X_i(Z)\rangle.$ |
We examine the dynamics of the subsystems
Dynamics of subsystem
$J_1(S, I) = \left(
−μ−βI2(S+I)2−βS2(S+I)2+h1βI2(S+I)2βS2(S+I)2−r1
\right).$
|
If we denote
$\delta_1 = (\mbox{tr}(J_1(S_1, I_1)))^2-4\mbox{det}(J_1(S_1, I_1))$ |
and the dynamics of system
Theorem 2.4. There is a disease-free equilibrium
$S_1 = \frac{r_1I_1}{\beta-r_1}, \ I_1 = \frac{(\beta-r_1)\Lambda}{\mu r_1+(\mu+\nu)(\beta-r_1)}, $ |
which is a stable node for
Dynamics of subsystem
$a_0 = \beta\mu+\nu(\beta-r_0), a_1 = b\beta(\mu+\nu)+\Lambda(r_0-\beta)-b\nu r_1, \ a_2 = b\Lambda(r_1-\beta)$ |
and
$C_0 = [\beta b(\mu+\nu)-\Lambda(r_0-\beta)-b\nu r_1]^2+4\beta\mu b\Lambda(h_0-h_1).$ |
One can verify that there are two possible endemic equilibria of system
$S_i = \frac{\Lambda-(\mu+\nu)I_i}{\mu}, \ I_2 = \frac{-a_1+\sqrt{C_0}}{2a_0}, \ I_3 = \frac{-a_1-\sqrt{C_0}}{2a_0}.$ |
Only one endemic equilibrium
$S∗=Λ−(μ+ν)I∗μ,I∗=−a12a0,S4=Λ−(μ+ν)I4μ,I4=bΛ(β−r1)bν(r0−r1)+Λ(r0−β).
$
|
We address the existence of equilibria for system
Theorem 2.5. The disease-free equilibrium
Range of parameter values | Existence of endemic equilibria | |
Nonexistence | ||
Nonexistence | ||
Nonexistence | ||
Nonexistence |
The disease-free equilibrium
$J_2(S, I) = \left(
−μ−βI2(S+I)2−βS2(S+I)2+(h1−h0)b2(b+I)2+h0βI2(S+I)2βS2(S+I)2−(h1−h0)b2(b+I)2−r0
\right).$
|
For any endemic equilibrium
$tr(J2(¯S,¯I))=(−β+r0−μ)¯I2+2b(r1−β−μ)¯I+(−μ−β+r1)b2(b+¯I)2,det(J2(¯S,¯I))=μ{[(β−r0)Λ+νb(r1−r0)]¯I2+2Λb(β−r1)¯I+Λb2(β−r1)}(Λ−ν¯I)(b+¯I)2. $
|
One can get that the unique endemic equilibrium
For the coexistence of
$\mbox{sgn}\Big(\mbox{det}\big(J_2(\overline{S}, \overline{I})\big)\Big) = \mbox{sgn} \Big(\mathcal{A}\overline{I}^2+ 2\Lambda b(\beta-r_1)\overline{I}+\Lambda(\beta-r_1)b^2\Big)$ |
with
$\mathcal{A} = \big((\beta-r_0)\Lambda+\nu b(\beta-r_0)-\nu b(\beta-r_1)\big)>0, $ |
then
$\mbox{det}\big(J_2(S_2, I_2)\big)>0, \ \mbox{det}\big(J_2(S_3, I_3)\big)<0. $ |
This indicates that
$\mbox{tr}\big(J_2(S_2, I_2)\big) =\frac{(\nu+h_0-\beta)I_2^2+2b(\nu+h_1-\beta)I_2+(\nu+h_1-\beta)b^2} {(b+I_2)^2}.$ |
It follows that
$sgn(tr(J2(S2,I2)))=sgn((ν+h0−β)I22+2b(ν+h1−β)I2+(ν+h1−β)b2)=sgn{[a1(2a0bp1−a1p0)+2a0(a2p0−a0b2p1)]−(2a0bp1−a1p0)√C0},
$
|
where
$\mathcal{B} = a_1\big(2a_0bp_1-a_1p_0\big)+2a_0\big(a_2p_0-a_0b^2p_1\big)$ |
and
$\delta_2 = \Big[\mbox{tr}(J_2(S_2, I_2))\Big]^2-4\mbox{det}(J_2(S_2, I_2)).$ |
Then one can verify that
(ⅰ)
(ⅱ)
For the existence of endemic equilibrium
$det(J2(S4,I4))=μ(β−r1)C(bν+Λ)2(β−r0)2(h1−h0)>0,tr(J2(S4,I4))=(β−r0−μ)−[bν(h0−h1)+Λ(r0−β)]2(h1−h0)(Λ+bν)2<0,
$
|
where
$\mathcal{C} = -\mu\nu\beta b^2(h_1-h_0)^2+2b\mu\beta\Lambda(r_0-\beta)(h_1-h_0)-\Lambda^2(r_0-\beta)^3, $ |
we conclude that
Theorem 2.6. (i) If
(ⅱ)If there are two endemic equilibria
(ⅲ) If only one endemic equilibrium
By implementing similar discussion as in [35], we obtain the rich dynamics of system
Theorem 2.7. (i) If there are two endemic equilibria
$\nu+h_0<\beta<\nu+h_1, \displaystyle\frac{p_1}{p_0}>\frac{a_1}{2a_0b}, (2a_0bp_1-a_1p_0)^2C_0 = \mathcal{B}^2.$ |
(ⅱ) Bogdanov-Takens bifurcation occurs if
$\nu+h_0<\beta<\nu+h_1, \displaystyle\frac{p_1}{p_0}>\frac{a_1}{2a_0b}, (2a_0bp_1-a_1p_0)^2C_0 = \mathcal{B}^2.$ |
To establish the dynamics given by the Filippov system (4), the first step is to rigorously define the local trajectory through a point
Existence of sliding mode. Indeed, no attracting sliding mode region exists for Filippov system (4) due to the mechanisms of our model. Solving
$S_{c1} = \frac{(\mu+\nu+h_1)I_c}{\beta-(\mu+\nu+h_1)}, \ S_{c2} = \frac{[(b+I_c)(\mu+\nu+h_0)+b(h_1-h_0)]I_c}{(b+I_c) (\beta-(\mu+\nu+h_0))-b(h_1-h_0)}. $ |
The repulsing sliding mode region takes the form
$\Sigma_e = \{(S, I_c):S_{c2}\leq S\leq S_{c1}\}\dot{ = }\Sigma_{e1}$ |
for
$\Sigma_e = \{(S, I_c):S\geq S_{c2}\}\dot{ = }\Sigma_{e2}$ |
for
$ \frac{\mathrm{d}S}{\mathrm{d}t} = -\mu\bigg[ S-\frac{\Lambda-(\mu+\nu)I_c}{\mu}\bigg]\dot{ = }F_s(S, I_c). $ | (5) |
Equation (5) defines a one dimensional dynamical system on
We will define the type of equilibrium on the repulsing sliding mode
Definition 3.1. A point
The following definition gives a more detailed characterization of a tangency point.
Definition 3.2. A point
(a)
(b)
Furthermore, if
For case (a), we call a fold tangency point visible (invisible) if the trajectories of subsystem
An equilibrium
Note that
$S_s-S_{c1} = \frac{(I_1-I_c)\big[\beta\mu+\nu(\beta-r_1)\big]} {\mu(\beta-r_1)}, $ |
we have
$S_s\leq S_{c1}\Longleftrightarrow I_c\geq I_1$ |
for
$S_s-S_{c2} = \frac{\big[\beta\mu+\nu(\beta-r_0)\big]I_c^2+ \big[b\beta(\mu+\nu)-\Lambda(\beta-r_0)-b\nu r_1\big]I_c-b\Lambda(r_1-\beta)} {-\mu(\beta-r_0)(I_c-I_{c0})}$ |
that
Then we conclude that the pseudo-equilibrium
(a)
(b)
(c)
Equilibria. We address all possible critical points for system (4) as follows.
Regular Equilibrium. In terms of Definition 2.1, the disease-free equilibrium
Boundary Equilibrium. There are up to five equilibria of Filippov system (4) colliding with the switching boundary
$E_1^b = \bigg(\frac{r_1I_c}{\beta-r_1}, I_{c1}\bigg), \ E_i^b = \bigg(\frac{\Lambda-(\mu+\nu)I_c}{\mu}, I_{ci}\bigg), i = 2, 3, 4, 5$ |
if
Pseudo-equilibrium. Only a pseudo-equilibrium
(a)
(b)
(c)
Furthermore, the pseudo-equilibrium
Tangency point. By Definition 2.3, two tangency points coexist for system (4) if
$E_1^t = (S_{c1}, I_c), E_2^t = (S_{c2}, I_c), $ |
and there is one tangency point
According to Definition 3.2, fold tangency points can be classified as visible and invisible ones, so we examine the type of tangency points
For
$\left\{
sgn(X2σ(Et1))=sgn(βSc1Sc1+Ic−b(h1−h0)b+Ic−r0)=1,X21σ(Et1)=βI2c(Sc1+Ic)2f11(Sc1,Ic)+[βS2c1(Sc1+Ic)2−r1]f12(Sc1,Ic),
\right.
$
|
that
$ \mbox{sgn}\big(X_1^2\sigma(E_1^t)\big) = \mbox{sgn}\Bigg( \frac{\Lambda(\beta-r_1)-\mu r_1I_{c}-(\mu+\nu)(\beta-r_1)I_{c}}{\beta-r_1}\Bigg), $ |
so if
For the tangency point
$\left\{
sgn(X1σ(Et2))=sgn((β−r1)Sc2−r1Ic)=−1,X22σ(Et2)=βI2c(Sc2+Ic)2f21(Sc2,Ic)+[βS2c2(Sc2+Ic)2−(h1−h0)b2(b+Ic)2−(μ+ν+h0)]f22(Sc2,Ic),
\right.$
|
so
$
sgn(X22σ(Et2))=sgn{−[μβ+ν(β−r0)]I2c+[Λ(β−r0)−b(βμ+βν−r1ν)]Ic+Λb(β−r1)(β−r0)Ic+b(β−r1)}.
$
|
(6) |
There are two possibilities according to whether
$I_3 < I_c<I_2\Rightarrow X_2^2\sigma(E_2^t)>0$ |
according to (6), so
Once we have examined the sliding dynamics as well as all possible critical points for system (4), we turn to discuss the discontinuity-induced bifurcation in the following section, which is special for Filippov system and refer to a type of bifurcations involving structural changes in the sliding mode domain.
In this section, we focus our attention on sliding bifurcation, in which some sliding segment on the switching boundary is involved. According to [29,17], all sliding bifurcations can be classified as local and global bifurcations. The local sliding bifurcations include boundary equilibrium bifurcation and double tangency bifurcation. Those sliding bifurcations are called global if they involve nonvanishing cycles. Global bifurcations include grazing (touching) bifurcation, sliding homoclinic bifurcation to pseudo-saddle, or pseudo-saddle-node or saddle, and the sliding heteroclinic bifurcation between pseudo-saddles, etc. In the following, we choose the threshold value
We initially examine the local sliding bifurcation for system (4), which include boundary equilibrium bifurcation and double tangency bifurcation. There are four distinguished boundary equilibrium bifurcations, i.e. boundary node (BN), boundary focus (BF), boundary saddle (BS) and boundary saddle-node bifurcation (BSN) [29,26]. Further, if the boundary equilibrium bifurcation involves changes of the real/virtual character, it is also termed as real/virtual equilibrium bifurcation. Double tangency bifurcation is a type of bifurcations triggered by the collision of two tangency points. Since the tangency points
Definition 4.1. A boundary equilibrium bifurcation occurs at a critical point
When a boundary equilibrium bifurcation occurs, we can observe two cases. One is persistence, where a real equilibrium becomes a pseudo-equilibrium; the other is non-smooth fold, where a real equilibrium disappears after colliding together with a pseudo-equilibrium. Implementing a similar discussion as in [17], one gets the conditions to distinguish between the two possible types of unfolding of a boundary equilibrium as the parameter
Definition 4.2. For system (4), if
$
det(J1(Sic1,Ic1))≠0∂σ(Ic1,Ic)∂Ic−J3(Sic1,Ic1)J−11(Sic1,Ic1)J4(Sic1,Ic1)≠0J3(Sic1,Ic1)J−11(Sic1,Ic1)(X2(Sic1,Ic1)−X1(Sic1,Ic1))≠0,
$
|
a non-smooth fold is observed for
$J_3(S_{ic1}, I_{c1})J_1^{-1}(S_{ic1}, I_{c1})\big(X_2(S_{ic1}, I_{c1})-X_1(S_{ic1}, I_{c1})\big)<0$ |
while persistence is derived at the boundary equilibrium bifurcation point for
$J_3(S_{ic1}, I_{c1})J_1^{-1}(S_{ic1}, I_{c1})\big(X_2(S_{ic1}, I_{c1})-X_1(S_{ic1}, I_{c1})\big)>0, $ |
where
The similar condition can be presented for other boundary equilibria and we omit them here.
For the case that only one endemic equilibrium
$det(J1(Eb1))=μr1I1S1+I1+(μ+ν)βI21(S1+I1)2,det(J1(Eb2))=β(μ+ν)I22(S2+I2)2+μ[βS2I2S2+I2+(h1−h0)I2b+I2],det(J2(Eb1))=[ν(r1+β)2+βμ(β−r1)][(β−r1)(Λ+bν)+bβμ]2−Cβ[(β−r1)(Λ+bν)+bβμ]2 $
|
with
$\mathcal{C} = \beta\mu(r_1-r_0)\big[(\beta-r_1)^2(\Lambda^2+2b\nu\Lambda)+ 2b\beta\mu\Lambda(\beta-r_1)\big], $ |
so a boundary focus (or node) bifurcation occurs for
For boundary equilibrium
$
sgn(J3(Sic1,Ic1)J−11(Sic1,Ic1)(X2(Sic1,Ic1)−X1(Sic1,Ic1)))=sgn{(h1−h0)Ic1b+Ic1[h1−μ−βI2c1(Sic1+Ic1)2−βS2ic1(Sic1+Ic1)2]}=sgn{(h1−μ−β)r21+2(h1−μ)r1(β−r1)+(h1−μ−β)(β−r1)2(β−r1)2}=sgn(−2r21+β(r1+ν+2h1−β)).
$
|
Thus, a non-smooth fold occurs if
$ -2r_1^2+\beta(r_1+\nu+2h_1-\beta)>0, $ | (7) |
while persistence is derived if
$ -2r_1^2+\beta(r_1+\nu+2h_1-\beta)<0. $ | (8) |
Implementing the similar process for boundary equilibrium
$sgn(J3(Sic2,Ic2)J−12(Sic2,Ic2)(X1(Sic2,Ic2)−X2(Sic2,Ic2)))=sgn{(h1−h0)Ic2b+Ic2[−h0+μ−(h1−h0)b2(b+Ic2)2+βI2c2(Sic2+Ic2)2+βS2ic2(Sic2+Ic2)2]}=sgn{(μ−h0)−b2(h1−h0)(b+Ic2)2+β[Λ−(μ+ν)Ic2]2+βμ2I2c2(Λ−νIc2)2}=sgn{(Λ−νIc2)2[(−h0+β+μ)(b+Ic2)2−b2(h1−h0)]−2μβIc2(b+Ic2)2[Λ−(μ+ν)Ic2]},
$
|
where
$ \frac{2\beta(b+I_{c2})^2}{b^2(h_1-h_0)-(b+I_{c2})^2(\beta+\mu-h_0)} <\frac{(\Lambda-\nu I_{c2})^2}{\mu I_{c2}\big[\Lambda-(\mu+\nu)I_{c2}\big]} $ | (9) |
while a non-smooth fold appears for
$ \frac{2\beta(b+I_{c2})^2}{b^2(h_1-h_0)-(b+I_{c2})^2(\beta+\mu-h_0)} >\frac{(\Lambda-\nu I_{c2})^2}{\mu I_{c2}\big[\Lambda-(\mu+\nu)I_{c2}\big]}. $ | (10) |
If we choose the parameters as
The pseudo-saddle
Note that the endemic equilibrium
$sgn(J3(Sc3,Ic3)J−12(Sc3,Ic3)(X1(Sc3,Ic3)−X2(Sc3,Ic3)))=sgn{(Λ−νIc3)2[(h0−β−μ)(b+Ic3)2+b2(h1−h0)]+2μβIc3(b+Ic3)2[Λ−(μ+ν)Ic3]},
$
|
where
It follows from Theorem 2.2 that a unique endemic equilibrium
For other cases with the existence of endemic equilibrium
Now we turn to examine the bifurcations of limit cycles of (4). Basically, there are three types of limit cycles for Filippov system (4) [29], i.e. standard periodic cycles, sliding periodic cycles and crossing periodic cycles. Standard periodic solutions refer to the cycles lying entirely in region
Grazing bifurcation. The bifurcation that occurs once the standard piece of a periodic cycle touches the switching boundary
It is worth noting that local sliding bifurcation happens at the critical threshold value
Bifurcation of a sliding homoclinic orbit to pseudo-saddle. If a pseudo-equilibrium of system (4) is a pseudo-saddle, it can have a sliding trajectory which initiates and returns back to it at certain threshold parameter values. This is indeed the so-called sliding homoclinic orbit. If a sliding cycle collides with such a pseudo-saddle, a sliding homoclinic bifurcation occurs as shown in Fig. 4(e)-(g). It follows from Fig. 4(e) that a sliding cycle, two pieces of stable manifolds and unstable manifolds of the pseudo-saddle
It follows from Fig. 4 that as the threshold level increases from 4 to 6.8556, Filippov system (4) exhibits the interesting local and global sliding bifurcations sequentially, i.e. boundary saddle bifurcation
One of our purposes in this study is to seek better strategies for curbing the spread of diseases, and to examine when and how to implement the control measure to contain the number of infected individuals to be less than some acceptable level if it is almost impossible to eradicate an infectious disease. An efficient way is to reduce the level of infected cases in steady state as small as possible. To realize this goal, we will examine the impact of parameters associated with interventions on the dynamics, especially the equilibrium level of infected individuals of Filippov system (4) in this section. Due to the biological significance of each parameter and their effect on disease control, we focus only on the impact of threshold parameter
Impact of threshold level
It is clear that the pseudo-equilibria and sliding modes are sensitive to the threshold level
It follows from the above discussion that we can increase the threshold level
Impact of HBPR parameter
The above discussion demonstrates that only endemic equilibrium of free system exists for Filippov system (4) by increasing the HBPR (i.e.
Note that here increasing
Impact of the maximum and minimum treatment rate. In this section, we focus on the impact of maximum and minimum per capita treatment rate (i.e.
Fig. 7 is to show the variation of the number of infected individuals in steady states as the maximum per capita treatment rate
$h12=4βμbΛ−2D1−√(4βμbΛ−2D1)2−4b2ν2(D21+4βμbr0Λ)2b2ν2−(μ+ν),D1=bν[Λ(r0−β)−βb(μ+ν)],
$
|
respectively. Denote
$L1={(S,I)∈R2+: S=h11},L2={(S,I)∈R2+: S=h12}.
$
|
Then
It follows from Fig. 7 that
By choosing the minimum per capita treatment rate
$h01=2D2Λ−4βμbΛ−√(4βμbΛ−2D2Λ)2−4Λ2(D22−4βμbΛr1)2Λ2−(μ+ν),D2=βΛ−bνr1+bβ(μ+ν).
$
|
Denote
$L4={(S,I)∈R2+: S=h01}.
$
|
According to Fig. 8(a), the equilibrium number of infected cases for system
It has been observed that treatment programme plays a significant role in controlling the emerging and reemerging infectious diseases, such as HIV [36] and Ebola [23], and usually the control programme is implemented only when the number of infected individuals reaches or exceeds the threshold level
Based on the dynamics of two subsystems of the Filippov system, we investigate the long-term dynamical behavior, which reveals much more complex dynamics compared to those for the continuous counterpart. In particular, we have examined the sliding mode, pseudo-equilibrium, multiple attractors in Section 3 and Section 4, respectively. As the threshold value varies, bifurcation analysis of piecewise smooth systems [17,29] on the proposed Filippov epidemic model yields the following local sliding bifurcations theoretically, i.e. regular/virtual equilibrium bifurcation, boundary equilibrium bifurcation including BN (see Fig. 1), BF, BS (see Fig. 2) and BSN bifurcations (see Fig. 3), and global sliding bifurcations including grazing bifurcation (see Fig. 4) and sliding homoclinic bifurcation (see Fig. 4). Our results demonstrate that variety of threshold level can give rise to diversity of long-term dynamical behavior.
It is worth emphasizing that understanding of impact of threshold policy will lead to the development of effective control programmes for public health, so we have examined the impact of some key parameters related to the control measure in Section 5. According to Fig. 5(a), if the basic reproduction number is greater than unity, we can choose proper threshold level such that the real equilibrium of system
In most cases, it is impossible to eradicate an epidemic disease from the population. We have investigated how the maximum and minimum treatment rate affect the equilibrium level of infected individuals in Section 5. Fig. 7 and Fig. 8 show that the number of infected individuals at the steady state is closely related to the maximum and minimum per capita treatment rate. The maximum and minimum per capita treatment rate remain effective for reducing transmission during the outbreak. In particular, if
It is worth noting that we choose the size of infected individuals as an index. In fact, the number of susceptible individuals can also affect on the implementation of control measures, especially on those immunization policies, so it is more appropriate for modeling the impact of limited resources on vaccination policies. Moreover, it is more natural to choose the total number of susceptible individuals and infected individuals as an index, especially for the combined control measure based on treatment and vaccination policy, which may be difficult and interesting, and we leave this for future work.
In conclusion, we propose a Filippov epidemic model to study the impact of HBPR on the disease control by incorporating a piecewise defined treatment programme in this paper. The main results illustrate the significant role of switching treatment programme in response to the call of controlling the epidemic disease. Indeed, to illustrate the main idea, we formulate a simple SIS model without considering the effect of hospitalized infection. Generally, those hospitalized has no contact with susceptible individuals, so no transmission occurs. An SIH (susceptible-infective-hospitalized) model of three dimension could then be more natural, which we will consider in the future work.
The first author was supported by Scientific research plan projects of Shaanxi Education Department (16JK1047). Xiao was supported by the National Natural Science Foundation of China (NSFC, 11571273 and 11631012) and Fundamental Research Funds for the Central Universities(GK 08143042). Zhu was supported by NSERC of Canada. This research was finished when Wang visited Lamps and Department of Mathematics and Statistics, York University.
[1] |
Citrin DE (2017) Recent developments in radiotherapy. N Engl J Med 377: 1065–1075. doi: 10.1056/NEJMra1608986
![]() |
[2] | Hanna P, Shafiq J, Delaney GP, et al. (2017) The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits. Radiother Oncol 126: 191–197. |
[3] | Zubizarreta E, Van DJ, Lievens Y (2016) Analysis of global radiotherapy needs and costs by geographic region and income level. Clin Oncol 29: 84–92. |
[4] | Deloch L, Derer A, Hartmann J, et al. (2016) Modern radiotherapy concepts and the impact of radiation on immune activation. Front Oncol 6: 141. |
[5] | Baskar R, Dai J, Wenlong N, et al. (2014) Biological response of cancer cells to radiation treatment. Front Mol Biosci 1: 24. |
[6] | Awwad HK (1990) The Overall Radiobiological Effect: The Evolution of Radiation Damage, In: Radiation Oncology: Radiobiological and Physiological Perspectives, Developments in Oncology, Springer, Dordrecht, 3–15. |
[7] |
Mcmillian TJ, Tobi S, Mateos S, et al. (2001) The use of DNA double-strand break quantification in radiotherapy. Int J Radiat Oncol Biol Phys 49: 373–377. doi: 10.1016/S0360-3016(00)01467-X
![]() |
[8] | Chow JCL (2017) Dose Enhancement Effect in Radiotherapy: Adding Gold Nanoparticle to Tumour in Cancer Treatment. Nanostruct Cancer Ther 2017: 383–400. |
[9] |
Hanks GE, Hanlon AL, Schultheiss TE, et al. (1998) Dose escalation with 3D conformal treatment: Five-year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 41: 501–510. doi: 10.1016/S0360-3016(98)00089-3
![]() |
[10] | Purdy JA (1996) Volume and dose specification, treatment evaluation, and reporting for 3D conformal radiation therapy, In: Palta J, Mackie TR, eds. Teletherapy: Present and Future, College Park, Md, Advanced Medical Publishing, 235–251.. |
[11] |
Perez CA, Purdy JA, Harms WB, et al. (1995) Three-dimensional treatment planning and conformal radiation therapy: Preliminary evaluation. Radiother Oncol 36: 32–43. doi: 10.1016/0167-8140(95)01566-Y
![]() |
[12] |
Mesbahi A (2010) A review on gold nanoparticles radiosensitization effect in radiation therapy of cancer. Rep Pract Oncol Radiother 15: 176–180. doi: 10.1016/j.rpor.2010.09.001
![]() |
[13] |
Ghita M, Mcmahon SJ, Laura E (2017) A mechanistic study of gold nanoparticle radiosensitisation using targeted microbeam irradiation. Sci Rep 7: 44752. doi: 10.1038/srep44752
![]() |
[14] |
Haume K, Rosa S, Grellet S, et al. (2016) Gold nanoparticles for cancer radiotherapy: A review. Cancer Nanotechnol 7: 8. doi: 10.1186/s12645-016-0021-x
![]() |
[15] |
Mcmachon SJ, Hyland WB, Muir MF, et al. (2011) Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy. Radiother Oncol 100: 412–416. doi: 10.1016/j.radonc.2011.08.026
![]() |
[16] |
Cui L, Her S, Borst GR, et al. (2017) Radiosensitization by gold nanoparticles: Will they ever make it to the clinic? Radiother Oncol 124: 344–356. doi: 10.1016/j.radonc.2017.07.007
![]() |
[17] |
Her S, Jaffray DA, Allen C (2017) Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements. Adv Drug Deliv Rev 109: 84–101. doi: 10.1016/j.addr.2015.12.012
![]() |
[18] |
Chithrani DB, Jelveh S, Jalali F, et al. (2010) Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res 173: 719–728. doi: 10.1667/RR1984.1
![]() |
[19] | Chow JCL (2017) Application of Nanoparticle Materials in Radiation Therapy, In: Leticia Myriam Torres Martinez, Oxana Vasilievna Kharissova and Boris Ildusovich Kharisov (Eds.), Handbook of Ecomaterials, Springer Nature, Switzerland. |
[20] | Chow JCL (2016) Photon and electron interactions with gold nanoparticles: A Monte Carlo study on gold nanoparticle-enhanced radiotherapy. Nanobiomater Med Imaging 8: 45–70. |
[21] | Chow JCL (2015) Characteristics of secondary electrons from irradiated gold nanoparticle in radiotherapy, In: Mahmood Aliofkhazraei (Ed.), Handbook of nanoparticles, Springer International Publishing, Switzerland, Chapter 10, 41–65. |
[22] | Chow JCL (2018) Monte Carlo nanodosimetry in gold nanoparticle-enhanced radiotherapy, In: Maria F. Chan (Ed.), Recent advancements and applications in dosimetry, New York: Nova Science Publishers. Chapter 2. |
[23] |
Yamada M, Foote M, Prow TW (2015) Therapeutic gold, silver, and platinum nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7: 428–445. doi: 10.1002/wnan.1322
![]() |
[24] |
Jeynes JC, Merchant MJ, Spindler A, et al. (2014) Investigation of gold nanoparticle radiosensitization mechanisms using a free radical scavenger and protons of different energies. Phys Med Biol 59: 6431–6443. doi: 10.1088/0031-9155/59/21/6431
![]() |
[25] |
Hainfeld JF, Dilmanian FA, Zhong Z, et al. (2010) Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol 55: 3045–3059. doi: 10.1088/0031-9155/55/11/004
![]() |
[26] |
Hainfeld JF, Smilowitz HM, O'Conor MJ, et al. (2013) Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine 8: 1601–1609. doi: 10.2217/nnm.12.165
![]() |
[27] |
Daniel MC, Astruc D (2004) Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104: 293–346. doi: 10.1021/cr030698+
![]() |
[28] |
Saha K, Agasti SS, Kim C, et al. (2012) Gold nanoparticles in chemical and biological sensing. Chem Rev 112: 2739–2779. doi: 10.1021/cr2001178
![]() |
[29] |
Giljohann DA, Seferos DS, Daniel WL, et al. (2010) Gold nanoparticles for biology and medicine. Angew Chem 49: 3280–3294. doi: 10.1002/anie.200904359
![]() |
[30] |
Jans H, Huo Q (2012) Gold nanoparticle-enabled biological and chemical detection and analysis. Chem Soc Rev 41: 2849–2866. doi: 10.1039/C1CS15280G
![]() |
[31] |
Murphy CJ, Gole AM, Stone JW, et al. (2008) Gold nanoparticles in biology: Beyond toxicity to cellular imaging. Acc Chem Res 41: 1721–1730. doi: 10.1021/ar800035u
![]() |
[32] |
Jain S, Hirst DG, O'sullivan JM (2012) Gold nanoparticles as novel agents for cancer therapy. Br J Radiol 85: 101–113. doi: 10.1259/bjr/59448833
![]() |
[33] |
Chithrani BD, Ghazani AA, Chan WC (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6: 662–668. doi: 10.1021/nl052396o
![]() |
[34] |
Grzelczak M, Pérez-Juste J, Mulvaney P, et al. (2008) Shape control in gold nanoparticle synthesis. Chem Soc Rev 37: 1783–1791. doi: 10.1039/b711490g
![]() |
[35] |
Lechtman E, Chattopadhyay N, Cai Z, et al. (2011) Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location. Phys Med Biol 56: 4631. doi: 10.1088/0031-9155/56/15/001
![]() |
[36] |
Jiang W, Kim BY, Rutka JT, et al. (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3: 145. doi: 10.1038/nnano.2008.30
![]() |
[37] |
Albanese A, Tang PS, Chan WC (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14: 1–6. doi: 10.1146/annurev-bioeng-071811-150124
![]() |
[38] |
Binder K, Heermann D, Roelofs L, et al. (1993) Monte Carlo simulation in statistical physics. Comput Phys 7: 156–157. doi: 10.1063/1.4823159
![]() |
[39] |
Andreo P (1991) Monte Carlo techniques in medical radiation physics. Phys Med Biol 36: 861. doi: 10.1088/0031-9155/36/7/001
![]() |
[40] |
Metropolis N, Ulam S (1949) The Monte Carlo method. J Am Stat Assoc 44: 335–341. doi: 10.1080/01621459.1949.10483310
![]() |
[41] |
Chow JCL (2017) Internet-based computer technology on radiotherapy. Rep Pract Oncol Radiother 22: 455–462. doi: 10.1016/j.rpor.2017.08.005
![]() |
[42] | Chow JCL (2011) A performance evaluation on Monte Carlo simulation for radiation dosimetry using cell processor. J Comp Meth Sci Eng 11: 1–12. |
[43] | Chow JCL (2016) Performance optimization in 4D radiation treatment planning using Monte Carlo simulation on the cloud. J Comp Meth Sci Eng 16: 147–156. |
[44] |
Wang H, Ma Y, Pratx G, et al. (2011) Toward real-time Monte Carlo simulation using a commercial cloud computing infrastructure. Phys Med Biol 56: N175. doi: 10.1088/0031-9155/56/17/N02
![]() |
[45] |
Bernal MA, Bordage MC, Brown JM, et al. (2015) Track structure modeling in liquid water: A review of the Geant4-DNA very low energy extension of the Geant4 Monte Carlo simulation toolkit. Phys Med 31: 861–874. doi: 10.1016/j.ejmp.2015.10.087
![]() |
[46] |
Incerti S, Ivanchenko A, Karamitros M, et al. (2010) Comparison of GEANT4 very low energy cross section models with experimental data in water. Med Phys 37: 4692–4708. doi: 10.1118/1.3476457
![]() |
[47] | Villagrasa C, Francis Z, Incerti S (2010) Physical models implemented in the GEANT4-DNA extension of the GEANT-4 toolkit for calculating initial radiation damage at the molecular level. Rad Prot Dosim 143: 214–218. |
[48] |
Champion C, Incerti S, Perrot Y, et al. (2014) Dose point kernels in liquid water: An intra-comparison between GEANT4-DNA and a variety of Monte Carlo codes. Appl Radiat Isot 83: 137–141. doi: 10.1016/j.apradiso.2013.01.037
![]() |
[49] |
Butterworth KT, McMahon SJ, Currell FJ, et al. (2012) Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale 4: 4830–4838. doi: 10.1039/c2nr31227a
![]() |
[50] | Montenegro M, Nahar SN, Pradhan AK, et al. (2009) Monte Carlo simulations and atomic calculations for Auger processes in biomedical nanotheranostics. J Phys Chem A 113: 12364–12369. |
[51] |
He X, Cheng F, Chen ZX (2016) The lattice kinetic Monte Carlo simulation of atomic diffusion and structural transition for gold. Sci Rep 6: 33128. doi: 10.1038/srep33128
![]() |
[52] | Rogers DW, Walters B, Kawrakow I (2009) BEAMnrc users manual. Nrc Rep Pirs 509: 12. |
[53] |
Martinov MP, Thomson RM (2017) Heterogeneous multiscale Monte Carlo simulations for gold nanoparticle radiosensitization. Med Phys 44: 644–653. doi: 10.1002/mp.12061
![]() |
[54] |
Sakata D, Kyriakou I, Okada S, et al. (2018) Geant4-DNA track-structure simulations for gold nanoparticles: The importance of electron discrete models in nanometer volumes. Med Phys 45: 2230–2242. doi: 10.1002/mp.12827
![]() |
[55] |
Brown JM, Dimmock MR, Gillam JE, et al. (2014) A low energy bound atomic electron Compton scattering model for Geant4. Nucl Instrum Meth B 338: 77–88. doi: 10.1016/j.nimb.2014.07.042
![]() |
[56] |
Chow JCL, He C (2016) Gold nanoparticle DNA damage in radiotherapy: A Monte Carlo study. AIMS Bioeng 3: 352–361. doi: 10.3934/bioeng.2016.3.352
![]() |
[57] |
Cho SH (2005) Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: A preliminary Monte Carlo study. Phys Med Biol 50: N163–N173. doi: 10.1088/0031-9155/50/15/N01
![]() |
[58] |
Zhang SX, Gao J, Buchholz TA, et al. (2009) Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: A Monte Carlo simulation study. Biomed Microdevices 11: 925–933. doi: 10.1007/s10544-009-9309-5
![]() |
[59] |
Leung MK, Chow JCL, Chithrani BD, et al. (2011) Irradiation of gold nanoparticles by X-rays: Monte Carlo simulation of dose enhancements and the spatial properties of the secondary electrons production. Med Phys 38: 624–631. doi: 10.1118/1.3539623
![]() |
[60] |
Hwang C, Kim JM, Kim JH (2017) Influence of concentration, nanoparticle size, beam energy, and material on dose enhancement in radiation therapy. J Radiat Res 58: 405–411. doi: 10.1093/jrr/rrx009
![]() |
[61] |
Douglass M, Bezak E, Penfold S (2013) Monte Carlo investigation of the increased radiation deposition due to gold nanoparticles using kilovoltage and megavoltage photons in a 3D randomized cell model. Med Phys 40: 071710. doi: 10.1118/1.4808150
![]() |
[62] |
Zygmanski P, Liu B, Tsiamas P, et al. (2013) Dependence of Monte Carlo microdosimetric computations on the simulation geometry of gold nanoparticles. Phys Med Biol 58: 7961–7977. doi: 10.1088/0031-9155/58/22/7961
![]() |
[63] |
Cai Z, Pignol JP, Chattopadhyay N, et al. (2013) Investigation of the effects of cell model and subcellular location of gold nanoparticles on nuclear dose enhancement factors using Monte Carlo simulation. Med Phys 40: 114101. doi: 10.1118/1.4823787
![]() |
[64] |
Xie WZ, Friedland W, Li WB, et al. (2015) Simulation on the molecular radiosensitization effect of gold nanoparticles in cells irradiated by X-rays. Phys Med Biol 60: 6195–6212. doi: 10.1088/0031-9155/60/16/6195
![]() |
[65] |
Lin AW, Lewinski NA, West JL, et al. (2005) Optically tunable nanoparticle contrast agents for early cancer detection: Model-based analysis of gold nanoshells. J Biomed Opt 10: 064035. doi: 10.1117/1.2141825
![]() |
[66] |
Zagaynova EV, Shirmanova MV, Kirillin MY, et al. (2008) Contrasting properties of gold nanoparticles for optical coherence tomography: Phantom, in vivo studies and Monte Carlo simulation. Phys Med Biol 53: 4995–5009. doi: 10.1088/0031-9155/53/18/010
![]() |
[67] |
Kirillin M, Shirmanova M, Sirotkina M, et al. (2009) Contrasting properties of gold nanoshells and titanium dioxide nanoparticles for optical coherence tomography imaging of skin: Monte Carlo simulations and in vivo study. J Biomed Opt 14: 021017. doi: 10.1117/1.3122373
![]() |
[68] |
Arifler D (2013) Nanoplatform-based optical contrast enhancement in epithelial tissues: Quantitative analysis via Monte Carlo simulations and implications on precancer diagnostics. Opt Express 21: 3693–3707. doi: 10.1364/OE.21.003693
![]() |
[69] |
Manohar N, Jones BL, Cho SH (2014) Improving X-ray fluorescence signal for benchtop polychromatic cone-beam X-ray fluorescence computed tomography by incident X-ray spectrum optimization: A Monte Carlo study. Med Phys 41: 101906. doi: 10.1118/1.4895004
![]() |
[70] |
Albayedh F, Chow JCL (2018) Monte Carlo simulation on the imaging contrast enhancement in nanoparticle-enhanced radiotherapy. J Med Phys 43: 195–199. doi: 10.4103/jmp.JMP_141_17
![]() |
[71] |
Lechtman E, Mashouf S, Chattopadhyay N, et al. (2013) A Monte Carlo-based model of gold nanoparticle radiosensitization accounting for increased radiobiological effectiveness. Phys Med Biol 58: 3075. doi: 10.1088/0031-9155/58/10/3075
![]() |
[72] | Amato E, Italiano A, Leotta S, et al. (2013) Monte Carlo study of the dose enhancement effect of gold nanoparticles during X-ray therapies and evaluation of the anti-angiogenic effect on tumour capillary vessels. J Xray Sci Technol 21: 237–247. |
[73] |
Lin Y, Paganetti H, McMahon SJ (2015) Gold nanoparticle induced vasculature damage in radiotherapy: Comparing protons, megavoltage photons, and kilovoltage photons. Med Phys 42: 5890–5902. doi: 10.1118/1.4929975
![]() |
[74] |
Kakade NR, Sharma SD (2015) Dose enhancement in gold nanoparticle-aided radiotherapy for the therapeutic photon beams using Monte Carlo technique. J Cancer Res Ther 11: 94–97. doi: 10.4103/0973-1482.147691
![]() |
[75] | Zabihzadeh M, Moshirian T, Ghorbani M, et al. (2018) A Monte Carlo Study on Dose Enhancement by Homogeneous and Inhomogeneous Distributions of Gold Nanoparticles in Radiotherapy with Low Energy X-rays. J Biomed Phys Eng 8: 13–28. |
[76] |
Brivio D, Zygmanski P, Arnoldussen M, et al. (2015) Kilovoltage radiosurgery with gold nanoparticles for neovascular age-related macular degeneration (AMD): A Monte Carlo evaluation. Phys Med Biol 60: 9203–9213. doi: 10.1088/0031-9155/60/24/9203
![]() |
[77] | Zheng XJ, Chow JCL (2017) Radiation dose enhancement in skin therapy with nanoparticle addition: A Monte Carlo study on kilovoltage photon and megavoltage electron beams. World J Radiol 2017 9: 63–71. |
[78] |
Chow JCL, Leung MK, Jaffray DA (2012) Monte Carlo simulation on a gold nanoparticle irradiated by electron beams. Phys Med Biol 57: 3323–3331. doi: 10.1088/0031-9155/57/11/3323
![]() |
[79] |
Mehrnia SS, Hashemi B, Mowla SJ, et al. (2017) Enhancing the effect of 4MeV electron beam using gold nanoparticles in breast cancer cells. Phys Med 35: 18–24. doi: 10.1016/j.ejmp.2017.02.014
![]() |
[80] |
Lin Y, Mcmahon SJ, Scarpelli M, et al. (2014) Comparing gold nano-particle enhanced radiotherapy with protons, megavoltage photons and kilovoltage photons: A Monte Carlo simulation. Phys Med Biol 59: 7675–7689. doi: 10.1088/0031-9155/59/24/7675
![]() |
[81] |
Martínez-Rovira I, Prezado Y (2015) Evaluation of the local dose enhancement in the combination of proton therapy and nanoparticles. Med Phys 42: 6703–6710. doi: 10.1118/1.4934370
![]() |
[82] |
Cho J, Gonzalez-Lepera C, Manohar N, et al. (2016) Quantitative investigation of physical factors contributing to gold nanoparticle-mediated proton dose enhancement. Phys Med Biol 61: 2562–2581. doi: 10.1088/0031-9155/61/6/2562
![]() |
[83] |
Bahreyni Toossi MT, Ghorbani M, Mehrpouyan M, et al. (2012) A Monte Carlo study on tissue dose enhancement in brachytherapy: A comparison between gadolinium and gold nanoparticles. Australas Phys Eng Sci Med 35: 177–185. doi: 10.1007/s13246-012-0143-3
![]() |
[84] |
Asadi S, Vaez-zadeh M, Masoudi SF, et al. (2015) Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye. J Appl Clin Med Phys 16: 344–357. doi: 10.1120/jacmp.v16i5.5568
![]() |
[85] | Asadi S, Vaez-Zadeh M, Vahidian M, et al. (2016) Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: A Monte Carlo study. J Appl Clin Med Phys 17: 90–99. |
[86] | Yan H, Ma X, Sun W, et al. (2018) Monte Carlo dosimetry modeling of focused kV X-ray radiotherapy of eye diseases with potential nanoparticle dose enhancement. Med Phys. |
[87] |
Al-Musywel HA, Laref A (2017) Effect of gold nanoparticles on radiation doses in tumor treatment: A Monte Carlo study. Laser Med Sci 32: 2073–2080. doi: 10.1007/s10103-017-2329-0
![]() |
[88] |
Lai P, Cai Z, Pignol JP (2017) Monte Carlo simulation of radiation transport and dose deposition from locally released gold nanoparticles labeled with 111In, 177Lu or 90Y incorporated into tissue implantable depots. Phys Med Biol 62: 8581–8599. doi: 10.1088/1361-6560/aa9106
![]() |
[89] | Dimitriou NM, Tsekenis G, Balanikas EC, et al. (2017) Gold nanopartirlces, radiations and the immune system: Current insights into the physical mechanisms and the biological interactions of this new alliance towards cancer therapy. Pharmacol Therapeut 78: 1–17. |
[90] |
Mavragani IV, Nikitaki Z, Souli MP, et al. (2017) Complex DNA damage: A route to radiation-induced genomic instability and carcinogenesis. Cancers 9: 91. doi: 10.3390/cancers9070091
![]() |
1. | Weike Zhou, Aili Wang, Xia Wang, Robert A. Cheke, Yanni Xiao, Sanyi Tang, Impact of Hospital Bed Shortages on the Containment of COVID-19 in Wuhan, 2020, 17, 1660-4601, 8560, 10.3390/ijerph17228560 | |
2. | Lirong Liu, Changcheng Xiang, Guangyao Tang, Yuan Fu, Sliding Dynamics of a Filippov Forest-Pest Model with Threshold Policy Control, 2019, 2019, 1076-2787, 1, 10.1155/2019/2371838 | |
3. | Wenjie Qin, Xuewen Tan, Xiaotao Shi, Changcheng Xiang, IPM strategies to a discrete switching predator-prey model induced by a mate-finding Allee effect, 2019, 13, 1751-3758, 586, 10.1080/17513758.2019.1682200 | |
4. | Khalil Muqbel, Gabriella Vas, Gergely Röst, Periodic Orbits and Global Stability for a Discontinuous SIR Model with Delayed Control, 2020, 19, 1575-5460, 10.1007/s12346-020-00395-0 | |
5. | Salihu Sabiu Musa, Shi Zhao, Nafiu Hussaini, Abdulrazaq Garba Habib, Daihai He, Mathematical modeling and analysis of meningococcal meningitis transmission dynamics, 2020, 13, 1793-5245, 2050006, 10.1142/S1793524520500060 | |
6. | Ana María Pulecio-Montoya, Luis Eduardo López-Montenegro, Jhon Cerón-Caicedo, Sliding Dynamic in a 3-dimensional epidemiological system, 2021, 185, 03784754, 570, 10.1016/j.matcom.2021.01.015 | |
7. | Aili Wang, Yanni Xiao, Robert Smith, Multiple Equilibria in a Non-smooth Epidemic Model with Medical-Resource Constraints, 2019, 81, 0092-8240, 963, 10.1007/s11538-018-00544-2 | |
8. | Zhimin Chen, Kaihui Liu, Xiuxiang Liu, Yijun Lou, Modelling epidemics with fractional-dose vaccination in response to limited vaccine supply, 2020, 486, 00225193, 110085, 10.1016/j.jtbi.2019.110085 | |
9. | Hongyong Zhao, Liping Wang, Sergio Muniz Oliva, Huaiping Zhu, Modeling and Dynamics Analysis of Zika Transmission with Limited Medical Resources, 2020, 82, 0092-8240, 10.1007/s11538-020-00776-1 | |
10. | Aili Wang, Yanni Xiao, Robert Smith, Dynamics of a non-smooth epidemic model with three thresholds, 2020, 139, 1431-7613, 47, 10.1007/s12064-019-00297-z | |
11. | Yunhu Zhang, Yanni Xiao, Global dynamics for a Filippov epidemic system with imperfect vaccination, 2020, 38, 1751570X, 100932, 10.1016/j.nahs.2020.100932 | |
12. | Joshua Kiddy K. Asamoah, Farai Nyabadza, Zhen Jin, Ebenezer Bonyah, Muhammad Altaf Khan, Michael Y. Li, Tasawar Hayat, Backward bifurcation and sensitivity analysis for bacterial meningitis transmission dynamics with a nonlinear recovery rate, 2020, 140, 09600779, 110237, 10.1016/j.chaos.2020.110237 | |
13. | Salihu Sabiu Musa, Shi Zhao, Nafiu Hussaini, Salisu Usaini, Daihai He, Dynamics analysis of typhoid fever with public health education programs and final epidemic size relation, 2021, 10, 25900374, 100153, 10.1016/j.rinam.2021.100153 | |
14. | Hao Zhou, Biao Tang, Huaiping Zhu, Sanyi Tang, Bifurcation and Dynamic Analyses of Non-monotonic Predator–Prey System with Constant Releasing Rate of Predators, 2022, 21, 1575-5460, 10.1007/s12346-021-00539-w | |
15. | Aili Wang, Jin Guo, Yinjiao Gong, Xueying Zhang, Rong Yan, Modeling the effect of Fangcang shelter hospitals on the control of COVID‐19 epidemic, 2022, 0170-4214, 10.1002/mma.8427 | |
16. | Lin Hu, Shengfu Wang, Tingting Zheng, Zhenxiang Hu, Yuenan Kang, Lin-Fei Nie, Zhidong Teng, The Effects of Migration and Limited Medical Resources of the Transmission of SARS-CoV-2 Model with Two Patches, 2022, 84, 0092-8240, 10.1007/s11538-022-01010-w | |
17. | Yi Yang, Lirong Liu, Changcheng Xiang, Wenjie Qin, Switching dynamics analysis of forest-pest model describing effects of external periodic disturbance, 2020, 17, 1551-0018, 4328, 10.3934/mbe.2020239 | |
18. | Hao Zhou, Sanyi Tang, Complex Dynamics and Sliding Bifurcations of the Filippov Lorenz–Chen System, 2022, 32, 0218-1274, 10.1142/S0218127422501826 | |
19. | A. K. Misra, Jyoti Maurya, Modeling the importance of temporary hospital beds on the dynamics of emerged infectious disease, 2021, 31, 1054-1500, 103125, 10.1063/5.0064732 | |
20. | A. K. Misra, Jyoti Maurya, Mohammad Sajid, Modeling the effect of time delay in the increment of number of hospital beds to control an infectious disease, 2022, 19, 1551-0018, 11628, 10.3934/mbe.2022541 | |
21. | A. K. Misra, Jyoti Maurya, Bifurcation analysis and optimal control of an epidemic model with limited number of hospital beds, 2023, 16, 1793-5245, 10.1142/S1793524522501017 | |
22. | Guilherme Tavares da Silva, Ricardo Miranda Martins, Dynamics and stability of non-smooth dynamical systems with two switches, 2022, 108, 0924-090X, 3157, 10.1007/s11071-022-07384-9 | |
23. | Hao Zhou, Sanyi Tang, Bifurcation dynamics on the sliding vector field of a Filippov ecological system, 2022, 424, 00963003, 127052, 10.1016/j.amc.2022.127052 | |
24. | A. K. Misra, Jyoti Maurya, Allocation of hospital beds on the emergence of new infectious disease: A mathematical model, 2023, 33, 1054-1500, 043125, 10.1063/5.0133703 | |
25. | Ishfaq Ahmad, Hiromi Seno, An epidemic dynamics model with limited isolation capacity, 2023, 1431-7613, 10.1007/s12064-023-00399-9 | |
26. | Jin Yang, Likun Guan, Zhuo Chen, Yuanshun Tan, Zijian Liu, Robert A. Cheke, Bifurcation analysis of a nonlinear pulse SIR model with media coverage, 2023, 111, 0924-090X, 19543, 10.1007/s11071-023-08869-x | |
27. | Jyoti Maurya, Konstantin B. Blyuss, A. K. Misra, Prospective impact of healthcare facilities and infrastructure on infectious disease outbreak dynamics: a modeling study, 2024, 1951-6355, 10.1140/epjs/s11734-024-01224-0 | |
28. | Rajesh Ranjan Patra, Sarit Maitra, Discontinuous harvesting policy in a Filippov system involving prey refuge, 2024, 43, 2238-3603, 10.1007/s40314-024-02858-5 | |
29. | Hao Zhou, Qianqian Zhang, Sanyi Tang, Qualitative analysis of the sliding vector field in a Filippov food chain model with integrated pest management strategy, 2025, 490, 00963003, 129188, 10.1016/j.amc.2024.129188 | |
30. | Zhiqiong Fu, Hiromi Seno, SIRI+Q model with a limited capacity of isolation, 2025, 1431-7613, 10.1007/s12064-025-00437-8 |
Range of parameter values | Existence of endemic equilibria | |
Nonexistence | ||
Nonexistence | ||
Nonexistence | ||
Nonexistence |
Range of parameter values | Existence of endemic equilibria | |
Nonexistence | ||
Nonexistence | ||
Nonexistence | ||
Nonexistence |